Activity of Decitabine as Maintenance Therapy in Core Binding Factor Acute Myeloid Leukemia. Senapati J, Shoukier M, Garcia-Manero G, Wang X, et al. Am J Hematol 2022 Feb 12. doi: 10.1002/ajh.26496.

Read + Share

Amedeo Smart

Independent Medical Education

Senapati J, Shoukier M, Garcia-Manero G, Wang X, et al. Activity of Decitabine as Maintenance Therapy in Core Binding Factor Acute Myeloid Leukemia. Am J Hematol 2022 Feb 12. doi: 10.1002/ajh.26496.
PMID: 35150150